Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Posted on by Pencis

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Wenzhou Sixth People’s Hospital | China.

Author Profile

Scopus

🎓Education

Master’s Degree – Wenzhou Medical College

đź’ĽProfessional Experience

Mr. Jiang has held several key leadership positions in the healthcare sector. He serves as the Deputy Secretary of the Party Committee at Wenzhou Central Hospital and previously led as the President of the Sixth People’s Hospital of Wenzhou. During the COVID-19 pandemic, he played a critical role as the Leader of the COVID-19 Treatment Team in Wenzhou, ensuring effective patient care and outbreak control. Additionally, he led the Wenzhou Medical Team in Shanghai, where he also served as the Temporary Party Branch Secretary, overseeing medical operations and emergency response efforts.

đź“šAcademic Contributions

Mr. Jiang has made significant contributions to medical research, with 17+ SCI-indexed publications and over 30 articles in Chinese medical journals. He has also served as an editor of two medical books, further advancing knowledge in infectious disease management. His research efforts extend to national and provincial projects, where he has played a key role in developing innovative healthcare solutions and public health strategies.

🧑‍🔬Technical Skills 

Mr. Xiangao Jiang possesses advanced expertise in infectious disease diagnosis and treatment, specializing in managing hepatitis, chronic liver diseases, tuberculosis, and other critical infections. His proficiency extends to critical care management, where he has played a key role in handling complex and severe infectious disease cases. Additionally, his strong leadership in medical administration and public health response has been demonstrated through his roles in hospital management, pandemic control, and policy implementation, ensuring effective healthcare delivery and crisis management.

đź“šTeaching Experience

Tutor for postgraduate students at Wenzhou Medical University & Shanghai University

🏆Awards and Honors

Mr. Jiang’s outstanding contributions to medicine and healthcare have earned him the prestigious titles of Wenzhou Famous Doctor and Ou Yue Famous Doctor. His leadership and expertise have also been recognized through his selection as a Health Leading Talent under Zhejiang Province’s “Ten Thousand People Plan”, a distinction awarded to top professionals making significant impacts in their fields.

🔬Research Interests

Mr. Jiang’s research focuses on hepatitis and chronic liver diseases, with an emphasis on understanding disease progression and developing effective treatment strategies. He is also deeply engaged in infectious disease epidemiology, studying patterns and risk factors to enhance prevention and control measures. Additionally, his work in public health and outbreak management has contributed to improving emergency response strategies and healthcare policies, particularly in the face of emerging infectious threats.

📑Notable Publications 

‘Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China’
Authors: C. Qiu, Chaochao; X. Lin, Xiaoqing; Q. Zhang, Qiang; J. Shi, Jichan; X. Jiang, Xiangao
Year: 2025
Journal: BMC Infectious Diseases

‘Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus’
Authors: L. Wu, Lianpeng; N. Chen, Na; D. Xia, Dandan; X. Jiang, Xiangao
Year: 2025
Journal: Frontiers in Medicine

 ‘Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysisy’
Authors: X. Cai, Xiaoxiao; X. Xu, Xueqin; G. He, Guiqing; X. Jiang, Xiangao; L. Wu, Lianpeng
Year: 2024
Journal: BMC Infectious Diseases

‘Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant Mycobacterium tuberculosis isolates in Wenzhou, China‘

Authors: G. He, Guiqing; Q. Zheng, Qingyong; J. Wu, Jing; X. Jiang, Xiangao; X. Yu, Xia
Year: 2024
Journal: Microbiology Spectrum

Dr. Xiaotian Xu | Global Health | Best Researcher Award

Posted on by Pencis

Dr. Xiaotian Xu | Global Health | Best Researcher Award

Guilin Medical University | China.

Author Profile

Scopus

🎓Education

Assoc. Prof. Dr. Xiaotian Xu obtained his Ph.D. in Traditional Chinese Medicine from China Pharmaceutical University in 2017, building on his strong foundation with a B.Sc. in Traditional Chinese Medicine from the same institution in 2012. His academic journey has been dedicated to exploring the therapeutic potential of traditional medicine through modern scientific approaches.

đź’ĽProfessional Experience

Assoc. Prof. Dr. Xiaotian Xu has been serving as an Associate Professor at the School of Pharmacy, Guilin Medical University since 2021, where he focuses on research and education in pharmaceutical sciences. Prior to this, he worked as a Lecturer at the same institution from 2017 to 2021, contributing to academic development and advancing research in traditional medicine and pharmacology.

đź“šAcademic Contributions

Dr. Xu has published multiple high-impact research articles in Journal of Functional Foods, European Journal of Pharmaceutical Sciences, and Cell Death & Disease, focusing on anti-inflammatory compounds and cancer treatment.

🧑‍🔬Technical Skills 

Dr. Xiaotian Xu possesses extensive expertise in natural product extraction and analysis, utilizing advanced techniques to isolate bioactive compounds. His proficiency in molecular pharmacology and cell culture & bioassays enables him to investigate drug mechanisms at the cellular level. Additionally, he specializes in animal disease models for evaluating therapeutic efficacy and applies data analysis & bioinformatics to interpret complex biological data, driving innovative research in pharmaceutical sciences.

đź“šTeaching Experience

 Assoc. Prof. Dr. Xiaotian Xu is actively involved in teaching Pharmacology of Traditional Chinese Medicine, where he bridges classical knowledge with modern scientific principles. He also lectures on Drug Discovery and Development, guiding students through the processes of identifying and formulating new therapeutic agents. Additionally, he teaches Advanced Research Methods, equipping students with essential skills in experimental design, data analysis, and scientific writing to enhance their research capabilities.

🏆Awards and Honors

NSFC Grant Recipient (2024) for research on durian shell polysaccharides in inflammatory bowel disease

Chinese Patent Holder (2021) for a novel extraction method of p-hydroxybenzaldehyde

🔬Research Interests

Natural compounds in inflammatory disease treatment

Cancer stem cell suppression & ferroptosis

Pharmacological mechanisms of traditional medicine

📑Notable Publications 

“Deep learning-based discovery of compounds for blood pressure lowering effects”

Authors: Li, R.; Wu, T.; Xu, X.; Duan, X.; Wang, Y.
Year: 2025
Journal: Scientific Reports

“p-Hydroxy benzaldehyde, a phenolic compound from Nostoc commune, ameliorates DSS-induced colitis against oxidative stress via the Nrf2/HO-1/NQO-1/NF-ÎşB/AP-1 pathway”

Authors: Liu, M.; Guan, G.; Wang, Y.; Duan, X.; Xu, X.
Year: 2024
Journal: Phytomedicine

“Passion fruit peel fermentation extract and its active component kaempferol alleviate constipation and hemorrhoids in mice by downregulating ESR1 and PI3K/Akt pathways”

Authors: Xu, X.; Li, X.; Wei, X.; Duan, X.; Wang, Y.
Year: 2024
Journal: Journal of Functional Foods

“Characteristics and Influence Factors of Pb(II) Adsorption by Graphene Oxide-Montmorillonite Composite”

Authors: Zhifang, Z.; Xiaotian, X.; Dongxia, L.; Jinlin, C.; Jiyi, Z.
Year: 2024
Journal: Chemistry and Biodiversity

“p-Hydroxy benzaldehyde attenuates intestinal epithelial barrier dysfunction caused by colitis via activating the HNF-1β/SLC26A3 pathway”

Authors: Liu, M.; Wang, Y.; Xu, X.; Zhu, Y.; Duan, X.
Year: 2024
Journal: Frontiers in Pharmacology

Mrs. Jing Wu | Infectious Diseases | Best Researcher Award

Posted on by Pencis

Mrs. Jing Wu | Infectious Diseases | Best Researcher Award

Nanjing First Hospital | China.

Author Profile

Scopus

🎓Education

Mrs. Jing Wu graduated from Nanjing Medical University, where she developed a strong foundation in imaging and diagnostic techniques.

đź’ĽProfessional Experience

Currently, Mrs. Wu is a key member of the Department of Imaging at Nanjing Hospital, affiliated with Nanjing Medical University (Nanjing First Hospital). She specializes in respiratory imaging diagnosis and respiratory infection diagnosis, with extensive clinical and research experience.

🔬Technical Skills

Mrs. Wu is proficient in CT and MRI imaging, utilizing advanced techniques to diagnose and assess chest infections. She also has expertise in multidisciplinary team discussions and radiographic interpretation.

🔬Research Interests

Her research primarily focuses on chest infections, respiratory diseases, and advanced imaging techniques for diagnosis. She aims to improve diagnostic accuracy and treatment approaches for pulmonary conditions through innovative imaging.

📚Academic Contributions 

With over 20 published papers in prominent medical journals over the past five years, Mrs. Wu has significantly contributed to the field of respiratory imaging. Her notable works include articles on COVID-19 pneumonia, pulmonary infections, and Chlamydia psittaci pneumonia. Her impactful research can be found in journals like Eur Radiol, Quant Imaging Med Surg, and BMC Infect Dis.

🏅Achievements and Awards

Mrs. Wu has earned several prestigious awards, including the Second place in the China Radiographic Reading Competition and First prize in the Nanjing Medical University Young Doctor Lecture Competition. Her accolades showcase her leadership and expertise in radiology and chest imaging.

🎙️Teaching Experience

As a speaker at major conferences like the Chinese Radiology and Respiratory Annual Conference and the North American Radiology Conference, Mrs. Wu has shared her expertise in imaging diagnostics with peers and aspiring professionals.

đź“šBooks & Reviews

Mrs. Wu has co-authored two professional books and served as the deputy editor-in-chief. She is also a dedicated peer reviewer for the Chinese Journal of Tuberculosis and Respiratory Medicine.

🌍Global Contributions

She continues to play a significant role in the international radiology community, sharing her research and findings to advance the field of respiratory imaging diagnostics.

Mrs. Wu’s exceptional skills and contributions make her a key figure in respiratory imaging diagnosis with a profound impact on clinical practice and medical education.

đź“‘Notable Publications

“Chlamydia psittaci pneumonia – evolutionary aspects on chest CT”

Authors: Yang, N., Ou, Z., Sun, Q., Wu, J., Xue, C.
Publication Year: 2025
Journal: BMC Infectious Diseases

“Diagnosis and treatment experience of Chlamydia psittaci pneumonia: A multicenter retrospective study in China”

Authors: Deng, H., Shi, Y., Xie, M., Pan, L., Xue, X.
Publication Year: 2024
Journal: BMC Infectious Diseases

“Imaging analysis of pneumonic plague infection in Xizang, China: a case report and literature review”

Authors: Wang, W., Li, X., Wu, J., Fu, X., Li, B.
Publication Year: 2024
Journal: BMC Pulmonary Medicine

“CT and MRI Findings of Renal Angiomyolipoma With Lung Metastasis: A Case Report and Literature Review”

Authors: He, Z., Wu, J., Fu, X., Xu, H., Chen, Y.-C.
Publication Year: 2024
Journal: Clinical Respiratory Journal

“Clinical and CT diagnosis of 50 cases of Chlamydia psittaci pneumonia”

Authors: Wu, J., Pan, J., Han, C., Zhang, K., Chen, Y.-C.
Publication Year: 2023
Journal: Quantitative Imaging in Medicine and Surgery

Gerardo Guillen Nieto | Pandemic preparedness | Best Researcher Award

Posted on by Pencis

Gerardo Guillen Nieto | Pandemic preparedness | Best Researcher Award

Prof Dr. Gerardo Guillen Nieto, Center for Genetic Engineering and Biotechnology, Cuba.

Dr. Gerardo Guillen Nieto is a distinguished researcher specializing in pandemic preparedness and infectious disease management. Renowned for his innovative work in vaccine development and immunology, Dr. Guillen has significantly contributed to global health initiatives, leading critical studies that have informed public health policies and improved response strategies for emerging infectious threats. His dedication to advancing medical research and his impactful publications have earned him prestigious recognitions, including the Best Researcher Award for his exemplary contributions to pandemic readiness and prevention.

Profile:

Orcid  Profile

Education

Dr. Gerardo Guillen Nieto holds a B.Sc. in Chemistry (1986) and an M.Sc. in Organic Chemistry from Odessa University, Ukraine, and earned his Ph.D. in Biological Sciences from Havana University in 1995. He has been recognized as a Senior Researcher since 2001 and was appointed Full Professor at Havana University in 2018 and at the Latin American School of Medicine in 2019. His exceptional career also includes being named a Distinguished Professor-at-Large at the University of Electronic Science and Technology of China in 2018. Dr. Guillen is a respected member of both the Cuban Academy of Science (since 2012) and the World Academy of Science (since 2022), showcasing his international acclaim and contributions to the field.

 

Experience 

Since 1998, Dr. Gerardo Guillen Nieto has held the prominent position of Director of Biomedical Research at the Center for Genetic Engineering and Biotechnology in Havana, Cuba. In this role, he has led groundbreaking research initiatives, overseeing a wide range of projects focused on genetic engineering and biotechnological advancements that have had a substantial impact on public health and biomedical sciences both nationally and internationally.

 

Conclusion

In conclusion, Dr. Gerardo Guillen Nieto’s extensive career is marked by profound contributions to the fields of vaccine development and biotechnological research, showcasing a commitment to advancing global health. His leadership at the Center for Genetic Engineering and Biotechnology, along with his academic roles and membership in prestigious scientific organizations, underscore his influence in scientific innovation and education. Dr. Guillen’s impressive body of work, recognized through numerous awards and over 270 published scientific articles, highlights his dedication to combating some of the most pressing medical challenges of our time. His expertise and contributions have left an indelible mark on both the scientific community and public health initiatives worldwide.

Top Note Publications

Title: Carcinogenic Effect of Human Tumors-Derived Cell Free-Filtrates in Nude Mice

Authors: Gerardo Guillen et al.
Journal: Preprint
Year: 2023

Title: The effects of Phycocyanobilin on experimental arthritis involve the reduction in nociception and synovial neutrophil infiltration, inhibition of cytokine production, and modulation of the neuronal proteome

Authors: Gerardo Guillen et al.
Journal: Frontiers in Immunology
Year: 2023

Title: Intranasal HBsAg/HBcAg-Containing Vaccine Induces Neutralizing Anti-HBs Production in Hepatitis B Vaccine Non-Responders

Authors: Gerardo Guillen et al.
Journal: Vaccines
Year: 2023

Title: Endogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence: Hypothetical Reflections

Authors: Gerardo Guillen et al.
Journal: International Journal of Molecular Sciences
Year: 2023

Title: Reflections on Endogenous Biological Drivers in Diabetic Lower Limb Wounds Recurrence

Authors: Gerardo Guillen et al.
Journal: Preprint
Year: 2023